-
Mashup Score: 2NewsDetails - 2 year(s) ago
Contact Rachel Darwin, Senior Manager, Public Relations darwin@nccn.org, 267-622-6624 Cancer Patients Treated with Immunotherapy Can Safely Receive mRNA COVID-19 Vaccines, According to JNCCN Study Researchers find…
Source: NCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0NewsDetails - 2 year(s) ago
Contact Rachel Darwin, Senior Manager, Public Relations darwin@nccn.org, 267-622-6624 NCCN Updates Recommendations for COVID-19 Vaccination with Information on Bivalent Vaccines, Children with Cancer, and Other Developments …
Source: NCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Updated recommendations for COVID-19 Vaccination with information on bivalent vaccines, children with cancer, and other developments are now available. Learn more: https://t.co/tGNg5YR57l #CovidNCancer https://t.co/hUl8py3S29
-
-
Mashup Score: 0Interdisciplinary Approach and Patient/Family Partners to Improve Serious Illness Conversations in Outpatient Oncology - 2 year(s) ago
PURPOSE: We aimed to increase Serious Illness Conversations (SIC) from a baseline of, at or near, zero to 25% of eligible patients by December 31, 2020. METHODS: We assembled an interdisciplinary team inclusive of a family partner and used the Model for Improvement as our quality improvement framework. The team developed a SMART Aim, key driver diagram, and SIC workflow. Standardized screening…
Source: JCO Oncology PracticeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#JCOOP #QualityInAction: Implementing routine serious illness conversations (SIC) into #oncology practice during the #COVID19 pandemic improved EMR documentation of SIC (0→ >70%) in three small, medical oncology clinics @WaspGarrett https://t.co/B9nojapKS5 #COVIDnCancer https://t.co/aL7Ecf17EZ
-
-
Mashup Score: 0NewsDetails - 2 year(s) ago
Contact Rachel Darwin, Senior Manager, Public Relations darwin@nccn.org, 267-622-6624 Updated Guidance for COVID-19 Vaccination from NCCN Recommends Fifth mRNA Shot (Second Booster Dose) for…
Source: NCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Updated guidance for #COVID19 vaccination from NCCN includes the latest recommendations for immunocompromised people. Learn more: https://t.co/IX8oxZbFe6 #covidncancer https://t.co/yQNc2xKown
-
-
Mashup Score: 3Cancer-Specific Urgent Care Reduces Unplanned Emergency Department Visits During COVID-19 - 2 year(s) ago
A multifaceted approach at the James Cancer Hospital in Columbus, Ohio, was successful in curtailing unplanned emergency department (ED) use among patients with cancer during high prevalence of COVID-19.
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#NCCN2022: Cancer-specific urgent care reduces unplanned emergency department visits during #COVID19, based on experiences from @OSUCCC_James. https://t.co/QPCmN7CcuF #ASCODailyNews #COVIDncancer #cancercare
-
-
Mashup Score: 0Risk of Breakthrough COVID-19 Higher for Patients With Cancer - 2 year(s) ago
The risk of breakthrough COVID-19 was higher among patients who received the Pfizer-BioNTech vaccine.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Patients with cancer have a higher risk of breakthrough COVID-19 after vaccination when compared with patients who don’t have cancer, according to research published in @JCO_ASCO. https://t.co/cI2nE1wOQv #COVIDnCancer
-
-
Mashup Score: 1Protecting Cancer Patients Against COVID-19 - 2 year(s) ago
This ESMO Webinar Series is available to all healthcare professionals working in Oncology
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Join international experts for an overview of efficacy of #COVID19vaccines in pts w/ #cancer. Also highlighting novel technologies & research progress on 2nd generation vaccine development. ⏰ 23 Mar 18:30 CET ➡️ https://t.co/7puLI7IFta @HaanenJohn @PGrivasMDPhD #COVIDnCancer https://t.co/OHUSGJz4dA
-
-
Mashup Score: 1Predicting Outcomes of COVID-19 in Patients With Cancer - 2 year(s) ago
Findings from several studies can help clinicians predict outcomes of COVID-19 in patients with cancer.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Findings from several studies can help clinicians predict outcomes of COVID-19 in patients with cancer, according to a recent @myESMO webinar presentation. https://t.co/n9nNbn9YRn #COVIDnCancer
-
-
Mashup Score: 2NewsDetails - 2 year(s) ago
Contact Rachel Darwin, Senior Manager, Public Relations darwin@nccn.org, 267-622-6624 New Research in JNCCN Measures Drop in Cancer Detection Due to the COVID-19 Pandemic Study out of…
Source: NCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New research in @JNCCN demonstrates that many cancers have gone undetected due to the disruptions in the healthcare system in response to the COVID-19 pandemic. Learn more: https://t.co/7OIEDmtrfj #COVID19 #CovidNCancer https://t.co/y9JwvmGf45
-
-
Mashup Score: 3AACR report: COVID-19 created barriers to cancer screening and care, but accelerated research and telemedicine - The Cancer Letter - 2 year(s) ago
The COVID-19 pandemic disrupted cancer screening and treatment and exacerbated health disparities, but also created unexpected opportunities in cancer research and care, a recent report from the American Association for Cancer Research states. The AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care addresses the challenges presented by COVID-19, while noting […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
.@AACR report: COVID-19 created barriers to cancer screening and care, but accelerated research and telemedicine. #COVIDnCancer https://t.co/nvWCL6s0V5
-
According to a new @JNCCN study cancer patients treated with immunotherapy can safely receive mRNA COVID-19 vaccines. Learn more: https://t.co/qpOJ2a8gNI #CovidNCancer https://t.co/93d0CcXz2r